pyridinoline has been researched along with osteoprotegerin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golmia, RP; Scheinberg, MA; Sousa, BD | 1 |
| Akira, N; Hayato, K; Masaaki, T; Tetsuyuki, N; Yasunori, K | 1 |
| Bailey, LJ; Bollag, WB; Choudhary, V; Ding, KH; Elsalanty, M; Elsayed, R; Isales, CM; Johnson, MH; McGee-Lawrence, ME; Xu, J; Yu, K; Zhong, Q | 1 |
| Estaphan, S; Kamar, S; Mostafa, S; Rashed, L; Sabry, M | 1 |
4 other study(ies) available for pyridinoline and osteoprotegerin
| Article | Year |
|---|---|
Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: comment on the article by Gratacós et al.
Topics: Amino Acids; Glycoproteins; Humans; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing | 2002 |
Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis.
Topics: Alkaline Phosphatase; Amino Acids; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Collagen Type I; Etanercept; Female; Humans; Immunoglobulin G; Male; Middle Aged; Osteoprotegerin; Peptides; RANK Ligand; Receptors, Tumor Necrosis Factor | 2008 |
Protein kinase D1 conditional null mice show minimal bone loss following ovariectomy.
Topics: Amino Acids; Animals; Bone and Bones; Bone Density; Bone Resorption; Female; Mice, Knockout; Minerals; Organ Size; Osteoprotegerin; Ovariectomy; Protein Kinase C; RANK Ligand; Stem Cells; Tartrate-Resistant Acid Phosphatase | 2018 |
The cross-talk between matrix metalloproteinase-9, RANKL/OPG system and cardiovascular risk factors in ovariectomized rat model of postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Amino Acids; Animals; Bone Remodeling; Cardiovascular Diseases; Cholesterol; Cortical Bone; Disease Models, Animal; Female; Gene Expression Regulation; Humans; Inflammation; Lipoproteins, HDL; Matrix Metalloproteinase 9; NF-kappa B; Osteocalcin; Osteoporosis, Postmenopausal; Osteoprotegerin; Ovariectomy; RANK Ligand; Rats; Risk Factors; Tibia; Triglycerides | 2021 |